Market Tracker

07/23 3:48am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

122.54
Data as of Jul 22
 -3.00 / -2.39%
Today’s Change
89.76
Today|||52-Week Range
153.10
+4.38%
Year-to-Date

Today’s Trading

Previous close125.54
Today’s open125.88
Day’s range122.23 - 127.80
Volume2,856,509
Average volume (3 months)3,267,729
Market cap$41.9B
Dividend yield--
Data as of 4:03pm ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+39.54%
Earnings growth (next 5 years)+34.80%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book8.17

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+1.16+0.46%
AGNAllergan Inc-0.71-0.41%
ALXNAlexion Pharmaceutic...+4.60+2.82%
ACTActavis PLC+0.24+0.11%
Data as of 4:04pm ET, 07/22/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)$1.91
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts